Pharmaceutical Contract Development and Manufacturing Organization Market Size By 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size Analysis

Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Introduction
By Service Type
1. Introduction
  1. Service Type By Value
2. Drug Development Services
  1. By Value
3. Pharmaceutical Manufacturing Services
  1. By Value
  2. Pharmaceutical API Manufacturing Services
    1. Pharmaceutical API Manufacturing Services By Value
  3. Pharmaceutical FDF Manufacturing Services
    1. Pharmaceutical FDF Manufacturing Services By Value
4. Biologics Manufacturing Services
  1. By Value
  2. Biologics API Manufacturing Services
    1. Biologics API Manufacturing Services By Value
  3. Biologics FDF Manufacturing Services
    1. Biologics FDF Manufacturing Services By Value
5. Packaging & Labelling Services
  1. By Value
6. Fill-finish Services
  1. By Value
7. Others
  1. By Value
By Research Phase
1. Introduction
  1. Research Phase By Value
2. Pre-clinical
  1. By Value
3. Phase I
  1. By Value
4. Phase II
  1. By Value
5. Phase III
  1. By Value
6. Phase IV
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Big Pharmaceutical Companies
  1. By Value
3. Small & Mid-Sized Pharmaceutical Companies
  1. By Value
4. Generic Pharmaceutical Companies
  1. By Value
5. Others
  1. By Value

North America Market Analysis

Introduction
By Service Type
1. Introduction
  1. Service Type By Value
2. Drug Development Services
  1. By Value
3. Pharmaceutical Manufacturing Services
  1. By Value
  2. Pharmaceutical API Manufacturing Services
    1. Pharmaceutical API Manufacturing Services By Value
  3. Pharmaceutical FDF Manufacturing Services
    1. Pharmaceutical FDF Manufacturing Services By Value
4. Biologics Manufacturing Services
  1. By Value
  2. Biologics API Manufacturing Services
    1. Biologics API Manufacturing Services By Value
  3. Biologics FDF Manufacturing Services
    1. Biologics FDF Manufacturing Services By Value
5. Packaging & Labelling Services
  1. By Value
6. Fill-finish Services
  1. By Value
7. Others
  1. By Value
By Research Phase
1. Introduction
  1. Research Phase By Value
2. Pre-clinical
  1. By Value
3. Phase I
  1. By Value
4. Phase II
  1. By Value
5. Phase III
  1. By Value
6. Phase IV
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Big Pharmaceutical Companies
  1. By Value
3. Small & Mid-Sized Pharmaceutical Companies
  1. By Value
4. Generic Pharmaceutical Companies
  1. By Value
5. Others
  1. By Value
U.S.
1. By Service Type
  1. Introduction
    1. Service Type By Value
  2. Drug Development Services
    1. By Value
  3. Pharmaceutical Manufacturing Services
    1. By Value
    2. Pharmaceutical API Manufacturing Services
      1. Pharmaceutical API Manufacturing Services By Value
    3. Pharmaceutical FDF Manufacturing Services
      1. Pharmaceutical FDF Manufacturing Services By Value
  4. Biologics Manufacturing Services
    1. By Value
    2. Biologics API Manufacturing Services
      1. Biologics API Manufacturing Services By Value
    3. Biologics FDF Manufacturing Services
      1. Biologics FDF Manufacturing Services By Value
  5. Packaging & Labelling Services
    1. By Value
  6. Fill-finish Services
    1. By Value
  7. Others
    1. By Value
2. By Research Phase
  1. Introduction
    1. Research Phase By Value
  2. Pre-clinical
    1. By Value
  3. Phase I
    1. By Value
  4. Phase II
    1. By Value
  5. Phase III
    1. By Value
  6. Phase IV
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Big Pharmaceutical Companies
    1. By Value
  3. Small & Mid-Sized Pharmaceutical Companies
    1. By Value
  4. Generic Pharmaceutical Companies
    1. By Value
  5. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Service Type
1. Introduction
  1. Service Type By Value
2. Drug Development Services
  1. By Value
3. Pharmaceutical Manufacturing Services
  1. By Value
  2. Pharmaceutical API Manufacturing Services
    1. Pharmaceutical API Manufacturing Services By Value
  3. Pharmaceutical FDF Manufacturing Services
    1. Pharmaceutical FDF Manufacturing Services By Value
4. Biologics Manufacturing Services
  1. By Value
  2. Biologics API Manufacturing Services
    1. Biologics API Manufacturing Services By Value
  3. Biologics FDF Manufacturing Services
    1. Biologics FDF Manufacturing Services By Value
5. Packaging & Labelling Services
  1. By Value
6. Fill-finish Services
  1. By Value
7. Others
  1. By Value
By Research Phase
1. Introduction
  1. Research Phase By Value
2. Pre-clinical
  1. By Value
3. Phase I
  1. By Value
4. Phase II
  1. By Value
5. Phase III
  1. By Value
6. Phase IV
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Big Pharmaceutical Companies
  1. By Value
3. Small & Mid-Sized Pharmaceutical Companies
  1. By Value
4. Generic Pharmaceutical Companies
  1. By Value
5. Others
  1. By Value
U.K.
1. By Service Type
  1. Introduction
    1. Service Type By Value
  2. Drug Development Services
    1. By Value
  3. Pharmaceutical Manufacturing Services
    1. By Value
    2. Pharmaceutical API Manufacturing Services
      1. Pharmaceutical API Manufacturing Services By Value
    3. Pharmaceutical FDF Manufacturing Services
      1. Pharmaceutical FDF Manufacturing Services By Value
  4. Biologics Manufacturing Services
    1. By Value
    2. Biologics API Manufacturing Services
      1. Biologics API Manufacturing Services By Value
    3. Biologics FDF Manufacturing Services
      1. Biologics FDF Manufacturing Services By Value
  5. Packaging & Labelling Services
    1. By Value
  6. Fill-finish Services
    1. By Value
  7. Others
    1. By Value
2. By Research Phase
  1. Introduction
    1. Research Phase By Value
  2. Pre-clinical
    1. By Value
  3. Phase I
    1. By Value
  4. Phase II
    1. By Value
  5. Phase III
    1. By Value
  6. Phase IV
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Big Pharmaceutical Companies
    1. By Value
  3. Small & Mid-Sized Pharmaceutical Companies
    1. By Value
  4. Generic Pharmaceutical Companies
    1. By Value
  5. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Service Type
1. Introduction
  1. Service Type By Value
2. Drug Development Services
  1. By Value
3. Pharmaceutical Manufacturing Services
  1. By Value
  2. Pharmaceutical API Manufacturing Services
    1. Pharmaceutical API Manufacturing Services By Value
  3. Pharmaceutical FDF Manufacturing Services
    1. Pharmaceutical FDF Manufacturing Services By Value
4. Biologics Manufacturing Services
  1. By Value
  2. Biologics API Manufacturing Services
    1. Biologics API Manufacturing Services By Value
  3. Biologics FDF Manufacturing Services
    1. Biologics FDF Manufacturing Services By Value
5. Packaging & Labelling Services
  1. By Value
6. Fill-finish Services
  1. By Value
7. Others
  1. By Value
By Research Phase
1. Introduction
  1. Research Phase By Value
2. Pre-clinical
  1. By Value
3. Phase I
  1. By Value
4. Phase II
  1. By Value
5. Phase III
  1. By Value
6. Phase IV
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Big Pharmaceutical Companies
  1. By Value
3. Small & Mid-Sized Pharmaceutical Companies
  1. By Value
4. Generic Pharmaceutical Companies
  1. By Value
5. Others
  1. By Value
China
1. By Service Type
  1. Introduction
    1. Service Type By Value
  2. Drug Development Services
    1. By Value
  3. Pharmaceutical Manufacturing Services
    1. By Value
    2. Pharmaceutical API Manufacturing Services
      1. Pharmaceutical API Manufacturing Services By Value
    3. Pharmaceutical FDF Manufacturing Services
      1. Pharmaceutical FDF Manufacturing Services By Value
  4. Biologics Manufacturing Services
    1. By Value
    2. Biologics API Manufacturing Services
      1. Biologics API Manufacturing Services By Value
    3. Biologics FDF Manufacturing Services
      1. Biologics FDF Manufacturing Services By Value
  5. Packaging & Labelling Services
    1. By Value
  6. Fill-finish Services
    1. By Value
  7. Others
    1. By Value
2. By Research Phase
  1. Introduction
    1. Research Phase By Value
  2. Pre-clinical
    1. By Value
  3. Phase I
    1. By Value
  4. Phase II
    1. By Value
  5. Phase III
    1. By Value
  6. Phase IV
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Big Pharmaceutical Companies
    1. By Value
  3. Small & Mid-Sized Pharmaceutical Companies
    1. By Value
  4. Generic Pharmaceutical Companies
    1. By Value
  5. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Service Type
1. Introduction
  1. Service Type By Value
2. Drug Development Services
  1. By Value
3. Pharmaceutical Manufacturing Services
  1. By Value
  2. Pharmaceutical API Manufacturing Services
    1. Pharmaceutical API Manufacturing Services By Value
  3. Pharmaceutical FDF Manufacturing Services
    1. Pharmaceutical FDF Manufacturing Services By Value
4. Biologics Manufacturing Services
  1. By Value
  2. Biologics API Manufacturing Services
    1. Biologics API Manufacturing Services By Value
  3. Biologics FDF Manufacturing Services
    1. Biologics FDF Manufacturing Services By Value
5. Packaging & Labelling Services
  1. By Value
6. Fill-finish Services
  1. By Value
7. Others
  1. By Value
By Research Phase
1. Introduction
  1. Research Phase By Value
2. Pre-clinical
  1. By Value
3. Phase I
  1. By Value
4. Phase II
  1. By Value
5. Phase III
  1. By Value
6. Phase IV
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Big Pharmaceutical Companies
  1. By Value
3. Small & Mid-Sized Pharmaceutical Companies
  1. By Value
4. Generic Pharmaceutical Companies
  1. By Value
5. Others
  1. By Value
UAE
1. By Service Type
  1. Introduction
    1. Service Type By Value
  2. Drug Development Services
    1. By Value
  3. Pharmaceutical Manufacturing Services
    1. By Value
    2. Pharmaceutical API Manufacturing Services
      1. Pharmaceutical API Manufacturing Services By Value
    3. Pharmaceutical FDF Manufacturing Services
      1. Pharmaceutical FDF Manufacturing Services By Value
  4. Biologics Manufacturing Services
    1. By Value
    2. Biologics API Manufacturing Services
      1. Biologics API Manufacturing Services By Value
    3. Biologics FDF Manufacturing Services
      1. Biologics FDF Manufacturing Services By Value
  5. Packaging & Labelling Services
    1. By Value
  6. Fill-finish Services
    1. By Value
  7. Others
    1. By Value
2. By Research Phase
  1. Introduction
    1. Research Phase By Value
  2. Pre-clinical
    1. By Value
  3. Phase I
    1. By Value
  4. Phase II
    1. By Value
  5. Phase III
    1. By Value
  6. Phase IV
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Big Pharmaceutical Companies
    1. By Value
  3. Small & Mid-Sized Pharmaceutical Companies
    1. By Value
  4. Generic Pharmaceutical Companies
    1. By Value
  5. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Service Type
1. Introduction
  1. Service Type By Value
2. Drug Development Services
  1. By Value
3. Pharmaceutical Manufacturing Services
  1. By Value
  2. Pharmaceutical API Manufacturing Services
    1. Pharmaceutical API Manufacturing Services By Value
  3. Pharmaceutical FDF Manufacturing Services
    1. Pharmaceutical FDF Manufacturing Services By Value
4. Biologics Manufacturing Services
  1. By Value
  2. Biologics API Manufacturing Services
    1. Biologics API Manufacturing Services By Value
  3. Biologics FDF Manufacturing Services
    1. Biologics FDF Manufacturing Services By Value
5. Packaging & Labelling Services
  1. By Value
6. Fill-finish Services
  1. By Value
7. Others
  1. By Value
By Research Phase
1. Introduction
  1. Research Phase By Value
2. Pre-clinical
  1. By Value
3. Phase I
  1. By Value
4. Phase II
  1. By Value
5. Phase III
  1. By Value
6. Phase IV
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Big Pharmaceutical Companies
  1. By Value
3. Small & Mid-Sized Pharmaceutical Companies
  1. By Value
4. Generic Pharmaceutical Companies
  1. By Value
5. Others
  1. By Value
Brazil
1. By Service Type
  1. Introduction
    1. Service Type By Value
  2. Drug Development Services
    1. By Value
  3. Pharmaceutical Manufacturing Services
    1. By Value
    2. Pharmaceutical API Manufacturing Services
      1. Pharmaceutical API Manufacturing Services By Value
    3. Pharmaceutical FDF Manufacturing Services
      1. Pharmaceutical FDF Manufacturing Services By Value
  4. Biologics Manufacturing Services
    1. By Value
    2. Biologics API Manufacturing Services
      1. Biologics API Manufacturing Services By Value
    3. Biologics FDF Manufacturing Services
      1. Biologics FDF Manufacturing Services By Value
  5. Packaging & Labelling Services
    1. By Value
  6. Fill-finish Services
    1. By Value
  7. Others
    1. By Value
2. By Research Phase
  1. Introduction
    1. Research Phase By Value
  2. Pre-clinical
    1. By Value
  3. Phase I
    1. By Value
  4. Phase II
    1. By Value
  5. Phase III
    1. By Value
  6. Phase IV
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Big Pharmaceutical Companies
    1. By Value
  3. Small & Mid-Sized Pharmaceutical Companies
    1. By Value
  4. Generic Pharmaceutical Companies
    1. By Value
  5. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Thermo Fisher Scientific, Inc.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Lonza Group
WuXi Apptec
WuXi Biologics
AbbVie, Inc.
Catalent, Inc.
Samsung Biologics
Evonik Industries AG
FUJIFILM Holding Corporation
Siegfried Holding AG
Boehringer Ingelheim International
Merck KGaA
Almac Group
Charles River Laboratories
Asychem Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment